Optimal Therapeutics Announces the Signing of a Licensing Agreement with Kwowa Hakko USA for the Ingredient Cognizin(R) to be Included in Their Brain Function Formula Neurovar

CEDAR GROVE, NJ /Send2Press Newswire/ — Optimal Therapeutics announces the signing of a licensing agreement with Kwowa Hakko USA for the ingredient Cognizin(R) to be included in their brain function formula Neurovar.

Optimal Therapeutics company spokesperson Camille Westhoff states “Cognizin(R) is an exciting ingredient that immediately places the Neurovar formulation at the top in this competitive class.”

Neurovar also contains other quality ingredients like Phosphatidyl Serine, Bacopa Monniera, Alpha GPC, Ginkgo Biloba, Vinpocetine and Acetyl-L-Carnitine.

Optimal Therapeutics, a Neutraceutical manufacturer based in New Jersey, also produces Zyroxin, Zalestra, Phosoplex, Fematril, Viastat amongst other quality formulations. Optimal Therapeutics products can be found online at and at Amazon.

News Source: Optimal Therapeutics :: This press release was issued by Send2Press® and is Copyright © 2005 Neotrope® News Network – all rights reserved.

Part of the Neotrope® News Network, USA.